Cholesterol dynamics in rabbit liver: High-fat diet, olive oil, and synergistic dietary effects

• Published in: Biochemical and biophysical research communications 2024-11, Vol.733, p.150675, Article 150675
• Main Authors: Funes, Abi K., Avena, Virginia, Boarelli, Paola V., Monclus, María A., Zoppino, Dario Fernández, Saez – Lancellotti, Tania E., Fornes, Miguel W.
• Format: Article
• Language: English
• Subjects: HMGCR (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase); LDL receptor (LDLR); Lipid metabolism; MAFLD (metabolic dysfunction-associated fatty liver disease); Sterol regulatory element-binding protein 2 (SREBP2)
• ISSN: 0006-291X; 1090-2104; 1090-2104
• DOI: 10.1016/j.bbrc.2024.150675

Lipid metabolism disorders contribute to a range of human diseases, including liver-related pathologies. Rabbits, highly sensitive to dietary cholesterol, provide a model for understanding the development of liver disorders. Sterol regulatory element-binding protein isoform 2 (SREBP2) crucially regulates intracellular cholesterol pathways. Extra-virgin olive oil (EVOO) has shown reducing cholesterol levels and restoring liver parameters affected by HFD. The aim was to investigate the molecular impact of an HFD and supplemented with EVOO on rabbit liver cholesterol metabolism. Male rabbits were assigned to dietary cohorts, including control, acute/chronic HFD, sequential HFD with EVOO, and EVOO. Parameters such as serum lipid profiles, hepatic enzymes, body weight, and molecular analyses. After 6 months of HFD, plasma and hepatic cholesterol increased with decreased SREBP2 and 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR) expression. Prolonged HFD increased cholesterol levels, upregulating SREBP2 mRNA and HMGCR protein. Combining this with EVOO lowered cholesterol, increased SREBP2 mRNA, and upregulated low-density lipoprotein receptor (LDLR) expression. HFD-induced metabolic dysfunction-associated fatty liver disease was mitigated by EVOO. In conclusion, the SREBP2 system responds to dietary changes. In rabbits, the SREBP2 system responds to dietary changes. Acute HFD hinders cholesterol synthesis, while prolonged HFD disrupts regulation, causing SREBP2 upregulation. EVOO intake prompts LDLR upregulation, potentially enhancing cholesterol clearance and restoring hepatic alterations. [Display omitted] •EVOO lowers HFD cholesterol, boosts SREBP2 mRNA.•EVOO boosts LDLR, aiding cholesterol clearance.•EVOO mitigates HFD-induced MAFLD in rabbits.